Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy

@inproceedings{Gannon2018SmokingIP,
  title={Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy},
  author={Nicholas P. Gannon and David M King and Manpreet Bedi},
  booktitle={Clinical sarcoma research},
  year={2018}
}
Background Soft tissue sarcomas (STS) are often treated with pre-operative radiation (RT), with or without chemotherapy, followed by wide local excision. Prognosis for these patients involves an interplay of tumor and patient characteristics. Known prognostic determinants include tumor size, grade, response to therapy, and patient characteristics such as age. While smoking is negatively correlated with outcomes in various malignancies, the impact on STS is unknown. We aimed to assess if smoking… CONTINUE READING
0 Citations
41 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 41 references

25 years of progress

  • CDC. The surgeon general’s 1989 report on reducing the smoking
  • MMWR. 1989;38(2):1–32. Page 7 of 7 Gannon et al…
  • 2018
1 Excerpt

Similar Papers

Loading similar papers…